RSV/RV coinfection was independently associated with a higher likelihood of bronchiolitis relapse compared to sole RSV infection (OR 1.54; 95% CI 1.03-2.30; P=0.03).
Cohort (n=1,836)
Sí
Does RSV/RV coinfection increase the risk of bronchiolitis relapse in hospitalized children with bronchiolitis compared to sole RSV infection?
In children hospitalized with bronchiolitis, RSV/RV coinfection is independently associated with a higher likelihood of short-term relapse compared to sole RSV infection.
Estimación del efecto: OR 1.54 (95% CI 1.03-2.30)
valor p: p=0.03
BACKGROUND: It is unclear whether the infectious etiology of severe bronchiolitis affects short-term outcomes, such as posthospitalization relapse. We tested the hypothesis that children hospitalized with rhinovirus (RV) bronchiolitis, either as a sole pathogen or in combination with respiratory syncytial virus (RSV), are at increased risk of relapse. METHODS: We performed a 16-center, prospective cohort study of hospitalized children age <2 years with bronchiolitis. During the winters of 2007-2010, researchers collected clinical data and nasopharyngeal aspirates from study participants; the aspirates were tested using real-time polymerase chain reaction. The primary outcome was bronchiolitis relapse (urgent bronchiolitis visit or scheduled visit at which additions to the bronchiolitis medications were made) during the 2 weeks after hospital discharge. RESULTS: Among 1836 enrolled children with 2-week, follow-up data, the median age was 4 months and 60% were male. Overall, 48% had sole RSV infection, 8% had sole RV infection, and 13% had RSV/RV coinfection. Compared with children with sole RSV infection, and adjusting for 10 demographic and clinical characteristics and clustering of patients within hospitals, children with sole RV infection did not differ in their likelihood of relapse (odds ratio: 0.99; 95% confidence interval: 0.52-1.90; P = 0.98), whereas those with RSV/RV coinfection were more likely to have relapse (odds ratio: 1.54; 95% confidence interval: 1.03-2.30; P = 0.03). CONCLUSIONS: In this prospective, multicenter, multiyear study of children hospitalized with bronchiolitis, we found that RSV/RV coinfection was independently associated with a higher likelihood of bronchiolitis relapse. Present data support the concept that the infectious etiology of severe bronchiolitis affects short-term outcomes.
Hasegawa et al. (Thu,) conducted a cohort in Bronchiolitis (n=1,836). RSV/RV coinfection vs. Sole RSV infection was evaluated on Bronchiolitis relapse (urgent bronchiolitis visit or scheduled visit at which additions to the bronchiolitis medications were made) during the 2 weeks after hospital discharge (OR 1.54, 95% CI 1.03-2.30, p=0.03). RSV/RV coinfection was independently associated with a higher likelihood of bronchiolitis relapse compared to sole RSV infection (OR 1.54; 95% CI 1.03-2.30; P=0.03).